Strategic Health Focus LaVoieHealthScience specializes in health science communications, blending investor relations with public relations for biopharma, medical tech, and public health sectors. This presents opportunities to offer integrated IR and PR programs to health tech startups and mid-stage companies seeking to differentiate in competitive markets.

Global Scale Advantage Affiliation with Omnicom Public Relations Group provides access to a global network of 2,000 health expert consultants across 100 countries. Sales reps can position this as a differentiator for clients pursuing international visibility, global rollout campaigns, or cross-border investor outreach.

Growing Leadership Recent leadership hires and promotions, including a new SVP of PR & communications and a Boston GM, indicate ongoing investment in senior expertise and regional expansion. This suggests capacity for larger engagements and dedicated account leadership for key accounts.

Awarded Reputation The firm has earned multiple industry awards, is rated among the top independent healthcare PR agencies, and has exposure on Inc. 5000 Fastest Growing Private Companies lists. This credibility can be leveraged to win opportunities with risk-averse health sector clients seeking proven partners.

Contractual & Funding Potential Recent government contract awards and a GSA MAS recognition imply opportunities to pursue public-sector clients or funded health initiatives, where compliance and established procurement pathways can shorten sales cycles for suitable programs.